M. Kasakin

Amino Acid and Acylcarnitine Levels in Chronic Patients with Schizophrenia: A Preliminary Study

N. Bokhan, E. Kornetova, A. Chernonosov, 2021, Metabolites.

Effect of Complexation with Arabinogalactan on Pharmacokinetics of “Guest” Drugs in Rats: For Example, Warfarin

O. S. Fedorova, A. Chernonosov, M. Khvostov, 2013, BioMed research international.

Synthesis of 2’-aminometylmorpholino nucleoside analogues containing the 4’-carboxymethyl linker group

V. Silnikov, T. Abramova, M. Kasakin, 2011, Russian Journal of Bioorganic Chemistry.

A protective chimeric antibody to tick-borne encephalitis virus.

N. Tikunova, A. Ryzhikov, L. Matveev, 2014, Vaccine.

Nucleotide Modifications Decrease Innate Immune Response Induced by Synthetic Analogs of snRNAs and snoRNAs

V. Govorun, E. Chernolovskaya, M. Pavlyukov, 2018, Genes.

Targeted metabolomics approach for identification of relapsing-remitting multiple sclerosis markers and evaluation of diagnostic models.

V. Koval, A. Rogachev, A. Pokrovsky, 2019, MedChemComm.

Changes in Amino Acid and Acylcarnitine Plasma Profiles for Distinguishing Patients with Multiple Sclerosis from Healthy Controls

V. Koval, A. Rogachev, A. Pokrovsky, 2020, Multiple sclerosis international.